Exhaustive Extractions

At iuvo, we work hard to stay on the cutting edge of new developments in testing and regulatory changes affecting the medical device and pharmaceutical industries. We will share these updates regularly here in our blog - Exhaustive Extractions.

FDA Lists ISO 10993-1:2018 as a Recognized Consensus Standard

On January 14, 2019, the FDA announced recognition (partial) of ISO 10993-1:2018 Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process.

 

In the Supplementary Information Sheet (SIS), it was noted that the FDA does not recognize Table A.1 in Annex A of the standard as it is in conflict with the FDA’s guidance “Use of International Standard ISO 10993-1, Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process (14 Sept 2016)."  The most notable differences between the ISO standard Table A.1 and the FDA guidance Table A.1, are that the FDA guidance Table A.1 does not include a column for “Physical and/or chemical information” and does include “Material-mediated pyrogenicity” as an endpoint for consideration for medical devices in contact with mucosal membranes for greater than 24 hours.   

The FDA notes that declarations of conformity, in support of premarket submissions, to the old standard will be accepted until 26 December 2020.  For more information on the FDA’s Standards and Conformity Assessment Program, visit the FDA website, located here

If you would like to learn more about the changes incorporated in ISO 10993-1:2018, or to speak to a member of our team about how this might impact your biocompatibility testing strategy, feel free to This email address is being protected from spambots. You need JavaScript enabled to view it..  Our toxicology consulting team is ready to support you!

iuvo CSO Mary Richardson Teaches Scouts About Entr...
ISO Publishes New Technical Standard: ISO/TS 2172...

Related Posts